Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Liquid Biopsies and Minimally-Invasive Diagnostics 2017

Shivani Sharma's Biography



Shivani Sharma, Associate Director, California NanoSystems Institute, California NanoSystems Institute, UCLA

Dr. Shivani Sharma holds a PhD in Biomedical Engineering and is Associate Director at the California NanoSystems Institute (CNSI) at University of California-Los Angeles, California, USA. Her expertise includes developing novel cell and tissue mechanics based biomarkers for cancer detection and chemosensitivity assays; high-resolution structural and mechanical mapping of exosomes, bio-molecules; and single molecule force spectroscopy for diagnostic and drug delivery applications. She leads the nanobiology R&D applications at the Nano & Pico Characterization Lab at CNSI.

She is a founding member of the International Society for Extracellular vesicles (ISEV), has chaired sessions as well as delivered invited talks at several International/National conferences related to exosomes and cancer diagnostics. She currently serves on the Editorial boards for Journal of Extracellular Vesicles and Journal of Circulating Biomarkers. Dr Sharma's work has featured in Chemical & Engineering News, Global Medical Discovery.com, Asia Research News and won the Physical Sciences Entrepreneurship and Innovation Award.

Shivani Sharma Image

Nano Analytical Tools for Extracellular Vesicles

Friday, 6 October 2017 at 15:00

Add to Calendar ▼2017-10-06 15:00:002017-10-06 16:00:00Europe/LondonNano Analytical Tools for Extracellular VesiclesLiquid Biopsies and Minimally-Invasive Diagnostics 2017 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

The analysis of exosomes and other extracellular vesicles (EVs) in body fluids could in future be the standard diagnostics in medicine, with growing evidence that the size, number concentration and biological composition of EVs are influenced by disease-including cancer, neurodegenerative diseases, and other anomalies and thus comprise of clinically relevant information. However the best utilization of this information warrants standardization of EVs for any downstream diagnostic analysis. I will discuss the application and impact of key EV metrology tools including Atomic Force Microscopy and Force Spectroscopy as well as recent findings in brain, breast and prostate cancer cell models.


Add to Calendar ▼2017-10-05 00:00:002017-10-06 00:00:00Europe/LondonLiquid Biopsies and Minimally-Invasive Diagnostics 2017Liquid Biopsies and Minimally-Invasive Diagnostics 2017 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com